Srakshinjeong 25 mg (Orphenadrine Hydrochloride)

Adult dosage

(Oral: tablets) Adults: Administer 2 tablets (50㎎) of orphenadrine hydrochloride orally 3 times daily. Dosage may be adjusted according to age and symptoms. (Injection) Adults: Administer 80-120㎎ (4-6㎖) of orphenadrine hydrochloride per day by intramuscular injection. Dosage may be adjusted according to age and symptoms.

This drug should not be used in patients with glaucoma. It should also not be administered to patients with obstruction of the pylorus or duodenum, or those with stenotic peptic ulcers. It is advisable not to use this drug in patients with benign prostatic hyperplasia or bladder neck obstruction. Patients with esophageal spasm or achalasia, as well as those with severe myasthenia gravis, should also avoid this medication. Patients who have an allergic reaction to this drug must never take it. Additionally, this drug contains lactose and should not be administered to patients with genetically determined galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with tachycardia or cardiovascular disease should exercise caution when using this medication. Patients with liver or kidney function problems should also be administered this drug carefully. Taking this medication may cause symptoms such as dry mouth, rapid heartbeat, constipation, urination problems, and blurred vision. Furthermore, various side effects such as drowsiness, nausea, vomiting, headache, dizziness, and skin rash may occur, so if symptoms are severe, consult a doctor. This drug can be habit-forming, so do not abruptly stop taking it; instead, gradually reduce the dosage under the guidance of a physician. Women who are pregnant or breastfeeding should use this drug only if the benefits outweigh the risks, as its safety is not established. Finally, safety has not been adequately confirmed for children or infants, so it should only be administered carefully when absolutely necessary.

• dry mouth
• palpitations
• constipation
• urinary disorders
• blurred vision
• abdominal pain
• drowsiness
• muscle tension
• nausea
• vomiting

This medication should be stored in a tightly sealed container that blocks light and kept at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's efficacy and safety.

Appearance

Pale yellow round tablets.

Package unit

30 tablets/bottle, 500 tablets/bottle